The unexpected absence of the Chinese fencing coach can only be due to one thing: Sinuvac’s (AMEX:SVA) reported a breakthrough with their new anti- H1N1 swine flu vaccine!

When I asked Bin Lu, my Chinese fencing coach, earlier this summer if he’d be embarking on his annual pilgrimage to China this summer, he seemed dubious.

“Afraid they put me in quarantine,” he said. “Swine flu.”

Indeed, his hesitation seemed reasonable: A volleyball team from my son’s high school spent most of their trip to China locked up in a Beijing hotel. And the Kawasaki delegation of Japanese scouts that part of our Boy Scout troop had been preparing to host for the better part of a year canceled their visit for fear of the porcine virus.

So I knew I was facing a turning point last night when I heard that Coach Bin had left for Shanghai, sticking me with a bunch of kids signed up for fencing lessons on Thursday night.

The news today confirmed my suspicions:

Sinovac Biotech Ltd. (AMEX:SVA) has developed a swine flu vaccine that is now safe. According to reports, it protects people after a single shot.

Inoculation has caused no severe adverse reactions in the 1,614 volunteers who received it, according to the company.

“The results are the first reported anywhere in the world on a vaccine to fight the new H1N1 strain that’s sparked the first influenza pandemic in 41 years,” said the company.

With U.S. vaccine manufacturers already behind schedule producing the amounts of vaccine ordered up by the U.S. government, that means Sinovac has the inside track on the world H1N1 vaccine market.

The stock rose over 10% today. Keep an eye on the stock… if U.S. manufacturers are not catching up, this one may be a medium-term winner.

Source: Sinuvac (SVA) Reports Swine Flu Success